| abstract |
Provided herein are methods, compounds, and compositions for reducing expression of a gp130 mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions for reducing inflammation in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate any one or more of inflammatory disease, cardiovascular disease or metabolic disease or a symptom thereof. |